Glenmark Pharmaceuticals announced that Hocine Sidi, Director of the company has resigned from the Board with effect from November 25, 2014.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,184 INR | +5.45% | +0.27% | +38.60% |
05-30 | Transcript : Glenmark Pharmaceuticals Limited - Analyst/Investor Day | |
05-29 | Assertio Therapeutics Names Brendan O'Grady as Chief Executive | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.60% | 3.79B | |
+18.09% | 41.07B | |
+24.16% | 22.65B | |
+20.11% | 14.14B | |
+52.15% | 12.09B | |
-0.05% | 6.79B | |
-10.97% | 6.91B | |
-8.87% | 5.73B | |
+15.28% | 5.59B | |
+4.00% | 4.82B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals Announces Resignation of Hocine Sidi as Director